ACTRN12614001086651已完成4 期
Effects of Fenofibrate on Intramyocardial Triglyceride Content and Left Ventricular Myocardial Function in patients with Type 2 Diabetes and Hypertriglyceridemia
Dr Arnold Ng0 个研究点目标入组 60 人开始时间: 2014年10月10日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years(—)
- 性别
- All
入选标准
- •1. Type 2 diabetes
- •2. Hypertriglyceridemia
排除标准
- •1. Atrial fibrillation
- •2. Current use of any fenofibrate or related fibrates
- •3. Contraindication to fenofibrate including: liver impairment demonstrated by abnormal liver function tests (greater than or equal to 3 times normal upper limit), chronic renal failure (eGFR <60mL/min), symptomatic gallbladder disease, myopathy/myositis (elevation of CK > 5 times upper limit of normal)
- •4. Contraindication to MRI including use of Gadolinium contrast
- •5. Current enrolment in any other drug trial
研究者
相似试验
进行中(未招募)
不适用
Efficacy of fenofibrate treatment on the insulin sensitivity and pancreas ß-cell function in obese patients with hypertriglyceridemia.Patients non-diabetic, obese with hypertriglyceridemia (previously untreated with fibrate).EUCTR2005-005698-31-HUational Medical Center (Országos Gyógyintézeti Központ)40
招募中
不适用
Safety Study of Fenofibrate During PregnancySevere Hypertriglyceridemia During PregnancyNCT05883865First People's Hospital of Hangzhou250
进行中(未招募)
4 期
Effect of Fenofibrate on Endothelial Dysfunction and Oxidative Stress in patients with Type 2 Diabetes Mellitus: an open label studytype 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12612000734864ita Cristina27
进行中(未招募)
1 期
Effect of intravenous iron on cardiac repairHeart failure with reduced left ventricular ejection fractionMedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2017-001623-44-BEZiekenhuis Oost Limburg (ZOL), Genk100
进行中(未招募)
1 期
Ciprofibrate and pre-diabetesInsulin resistance, diastolic cardiac failure, mitochondrial functionEUCTR2018-001663-22-NLMaastricht University12
